Tepezza (teprotumumab) has emerged as a groundbreaking treatment for thyroid eye disease, offering hope to patients with this rare condition. Approved by the FDA in January 2020, Tepezza has shown remarkable efficacy in reducing eye bulging and double vision. However, like any medication, it is important to be aware of the potential adverse events associated […]